January 26, 2022

From the Co-Chairs, January 2022

Hopes for a return to normalcy in 2022—plus, recent qualitative research identifies surprising barriers to the long-term control of breast cancer
December 22, 2021

Now Enrolling: EAQ201 to Assess COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST Participation

This observational study aims to assess the effects of the pandemic as a barrier to enrollment in the TMIST breast cancer screening trial
August 23, 2021

From the Co-Chairs, August 2021

Fall 2021 Group Meeting to be virtual; a new prevention trial; the case for COVID-19 vaccination
April 27, 2021

From the Co-Chairs, April 2021

With cherry blossoms finished weeks ago, and fragrant magnolia blooms littering paths, Philadelphia is well into spring, and that means it must be time for an ECOG-ACRIN Group Meeting
March 31, 2021

From the Co-Chairs, March 2021

What will 'clean-up' and recovery after COVID-19 entail?
February 25, 2021

From the Co-Chairs, February 2021

COVID-19 vaccination and patients with cancer; the impact of delayed screening; a virtual Spring 2021 Group Meeting
September 14, 2020

From the Co-Chairs, August/September 2020

Welcome to the News From ECOG-ACRIN blog; COVID-19 month six reflections; clinical trial enrollment continues to improve; EA Cancer Research Advocates Committee adds five new members
May 29, 2020

From the Co-Chairs, May 2020

What we know about COVID-19; remembering Valerie Guild; spotlight on Indiana University's Melvin and Bren Simon Comprehensive Cancer Center
May 29, 2020

NCI’s Natural History Study of COVID-19 in Cancer

The purpose of this trial is to better understand the coronavirus' effect on people with cancer
May 29, 2020

Lynne Wagner: COVID-19 Emotional Support Resources

April 15, 2020

From the Co-Chairs, March/April 2020

Seamless patient mangement during the pandemic; COVID-19 Virtual Town Hall for Community Physicians and Research Staff; remembering Dr. Uma Rao; recognizing the John H. Stroger, Jr. Hospital of Cook County Minority Underserved NCORP; spotlight on the EROS trial, which is evaluating a program to help women with cancer and their physicians plan for reproductive health and preservation of sexuality during and after cancer treatment